Empress Therapeutics Funding Round

6/21/2023

Venture Equity

$50,000,000

Undisclosed

Flagship Pioneering has launched its latest venture, taking the sheet off Empress Therapeutics to rapidly accelerate the development of small-molecule medicines, with the biotech planning to ask regulators to greenlight clinical trials multiple times in the next two years.

Private & Independent

Biopharmaceutical

790 Memorial Dr 2B
Cambridge, MA 02139
USA

Undisclosed

Empress makes the discovery of effective, easy-to-take, value-driven medicines more productive with a platform that finds starting points for drugs inside the human body. The discovery of biologic drugs based on proteins, information molecules, and cells has proven that inside the human body exists a rich source of bioactive molecules that can reliably inform drug products, drug targets, and biomarkers. Yet to date, drug discovery has largely overlooked the millions of unique chemical reactions, with billions more unique chemistries involved, that take place inside each of us to maintain health.